CHEMED CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CHEMED CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.53B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.43B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.26B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.13B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $2.14B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $2.08B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.94B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $1.78B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.67B | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $1.58B | Feb 27, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.53B | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | $1.32B | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | $1.20B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.26B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.33B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.28B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $1.20B | Feb 26, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.67B | Feb 26, 2018 |
| FY2016 | Dec 31, 2016 | $1.58B | Feb 27, 2017 |
| FY2015 | Dec 31, 2015 | $1.54B | Feb 26, 2016 |
| FY2014 | Dec 31, 2014 | $1.46B | Feb 27, 2015 |
| FY2013 | Dec 31, 2013 | $1.41B | Feb 27, 2014 |
| FY2012 | Dec 31, 2012 | $1.43B | Feb 27, 2013 |
| FY2011 | Dec 31, 2011 | $1.36B | Feb 27, 2012 |
| FY2010 | Dec 31, 2010 | $1.28B | Feb 28, 2011 |
| FY2010 | Dec 31, 2009 | $1.19B | Feb 28, 2011 |
| FY2010 | Dec 31, 2008 | $1.15B | Feb 28, 2011 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $265.24M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $302.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $272.51M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $249.62M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $268.55M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $319.47M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $219.92M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $205.54M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $98.18M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $108.74M | Feb 27, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $338.25M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $366.49M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $340.57M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $343.50M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $343.04M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $389.68M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $257.38M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $243.63M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $113.04M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $178.75M | Feb 27, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $417.19M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $424.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $395.12M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $358.73M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $366.73M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $330.22M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $305.71M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $271.21M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $276.65M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $243.57M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $388.27M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $417.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $330.30M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $309.89M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $308.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $489.29M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $301.25M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $287.14M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $162.50M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $135.39M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $49.53M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $56.85M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $57.33M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $58.68M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $58.83M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $53.02M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $52.87M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $64.30M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $39.77M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.67B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.67B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.44B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.34B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.43B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.27B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $975.53M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $920.03M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $880.06M | Feb 27, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $558.78M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $549.58M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $560.22M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $643.30M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $719.45M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $533.71M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $541.71M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $384.20M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $379.67M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $355.96M | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $979.41M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.12B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.11B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $798.72M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $623.27M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $901.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $726.61M | Feb 27, 2023 |
| FY2021 | Dec 31, 2018 | $591.33M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $540.35M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $524.10M | Feb 26, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $667.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $666.74M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $585.02M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $581.30M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $578.59M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $578.59M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $577.37M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $510.57M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $476.89M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $472.37M | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.96B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.72B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.45B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.20B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.97B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $1.72B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.43B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.23B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.04B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $958.15M | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.52M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $178.35M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $263.96M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $74.13M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $32.90M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $162.68M | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $6.16M | Feb 28, 2022 |
| FY2021 | Dec 31, 2018 | $4.83M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $11.12M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $15.31M | Feb 26, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $97.50M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $185.00M | Feb 27, 2023 |
| FY2020 | Dec 31, 2019 | $90.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $89.20M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $101.20M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $108.75M | Feb 26, 2018 |
| FY2016 | Dec 31, 2015 | $91.25M | Feb 27, 2017 |
| FY2015 | Dec 31, 2014 | $147.50M | Feb 26, 2016 |
| FY2013 | Dec 31, 2013 | $183.56M | Feb 27, 2014 |
| FY2013 | Dec 31, 2012 | $174.89M | Feb 27, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 20 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 18 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 16 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 17 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 20 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 13 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 12 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 6 | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | 6 | Feb 27, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 19 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 17 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 16 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 16 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 19 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 13 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 12 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 5 | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | 6 | Feb 27, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.70M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $27.09M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $23.50M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $22.02M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $22.02M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $21.08M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $19.79M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $18.66M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $17.37M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $16.44M | Feb 27, 2019 |